Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A study of Quadrivalent influenza vaccine

Trial Profile

A study of Quadrivalent influenza vaccine

Recruiting
Phase of Trial: Phase III

Latest Information Update: 08 Nov 2018

At a glance

  • Drugs Influenza-virus-vaccine-quadrivalent-Sinovac-Biotech (Primary)
  • Indications Influenza virus infections
  • Focus Therapeutic Use
  • Sponsors Sinovac Biotech
  • Most Recent Events

    • 08 Nov 2018 According to a Sinovac Biotech media release, the company expects to complete this study by 2018.
    • 11 May 2018 According to a Sinovac Biotech media release, this trial was initiated in the fourth quarter of 2017.
    • 11 May 2018 Status changed from planning to recruiting, as reported in a Sinovac Biotech media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top